PortfoliosLab logoPortfoliosLab logo
LGND vs. HYG
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

LGND vs. HYG - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Ligand Pharmaceuticals Incorporated (LGND) and iShares iBoxx $ High Yield Corporate Bond ETF (HYG). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LGND achieves a 50.69% return, which is significantly higher than HYG's 1.54% return. Over the past 10 years, LGND has outperformed HYG with an annualized return of 9.81%, while HYG has yielded a comparatively lower 4.99% annualized return.


LGND

1D
1.96%
1M
24.24%
YTD
50.69%
6M
44.52%
1Y
141.00%
3Y*
57.38%
5Y*
15.37%
10Y*
9.81%

HYG

1D
-0.03%
1M
0.44%
YTD
1.54%
6M
1.53%
1Y
5.62%
3Y*
8.74%
5Y*
3.66%
10Y*
4.99%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LGND vs. HYG - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LGND
Ligand Pharmaceuticals Incorporated
50.69%76.45%50.03%6.92%-56.75%55.31%-4.64%-23.15%-0.90%34.76%
HYG
iShares iBoxx $ High Yield Corporate Bond ETF
1.54%8.59%7.97%11.54%-10.98%3.76%4.47%14.09%-2.02%6.07%

Correlation

The correlation between LGND and HYG is 0.35, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.35

Correlation (3Y)
Calculated over the trailing 3-year period

0.36

Correlation (5Y)
Calculated over the trailing 5-year period

0.36

Correlation (10Y)
Calculated over the trailing 10-year period

0.33

Correlation (All Time)
Calculated using the full available price history since Apr 11, 2007

0.30

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LGND vs. HYG — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LGND
LGND Risk / Return Rank: 9797
Overall Rank
LGND Sharpe Ratio Rank: 9898
Sharpe Ratio Rank
LGND Sortino Ratio Rank: 9696
Sortino Ratio Rank
LGND Omega Ratio Rank: 9595
Omega Ratio Rank
LGND Calmar Ratio Rank: 9898
Calmar Ratio Rank
LGND Martin Ratio Rank: 9797
Martin Ratio Rank

HYG
HYG Risk / Return Rank: 5252
Overall Rank
HYG Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
HYG Sortino Ratio Rank: 4949
Sortino Ratio Rank
HYG Omega Ratio Rank: 4747
Omega Ratio Rank
HYG Calmar Ratio Rank: 5454
Calmar Ratio Rank
HYG Martin Ratio Rank: 6565
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LGND vs. HYG - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Ligand Pharmaceuticals Incorporated (LGND) and iShares iBoxx $ High Yield Corporate Bond ETF (HYG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


LGNDHYGDifference
Sharpe ratioReturn per unit of total volatility

+2.33

Sortino ratioReturn per unit of downside risk

+1.90

Omega ratioGain probability vs. loss probability

1.55

1.28

+0.27

Calmar ratioReturn relative to maximum drawdown

10.08

2.41

+7.67

Martin ratioReturn relative to average drawdown

25.50

10.57

+14.92

LGND vs. HYG - Sharpe Ratio Comparison

The current LGND Sharpe Ratio is 3.79, which is higher than the HYG Sharpe Ratio of 1.46. The chart below compares the historical Sharpe Ratios of LGND and HYG, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

LGND vs. HYG - Drawdown Comparison

The maximum LGND drawdown since its inception was -93.34%, which is greater than HYG's maximum drawdown of -34.25%. Use the drawdown chart below to compare losses from any high point for LGND and HYG.


Loading charts...

Drawdown Indicators


LGNDHYGDifference

Max Drawdown

Largest peak-to-trough decline

-93.34%

-34.25%

-59.09%

Max Drawdown (1Y)

Largest decline over 1 year

-14.07%

-2.34%

-11.73%

Max Drawdown (3Y)

Largest decline over 3 years

-31.79%

-4.56%

-27.23%

Max Drawdown (5Y)

Largest decline over 5 years

-70.11%

-15.79%

-54.32%

Max Drawdown (10Y)

Largest decline over 10 years

-81.94%

-22.03%

-59.91%

Current Drawdown

Current decline from peak

0.00%

-0.24%

+0.24%

Average Drawdown

Average peak-to-trough decline

-44.51%

-3.23%

-41.28%

Ulcer Index

Depth and duration of drawdowns from previous peaks

5.58%

0.53%

+5.05%

Volatility

LGND vs. HYG - Volatility Comparison

Ligand Pharmaceuticals Incorporated (LGND) has a higher volatility of 10.36% compared to iShares iBoxx $ High Yield Corporate Bond ETF (HYG) at 1.13%. This indicates that LGND's price experiences larger fluctuations and is considered to be riskier than HYG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LGNDHYGDifference

Volatility (1M)

Calculated over the trailing 1-month period

10.36%

1.13%

+9.23%

Volatility (6M)

Calculated over the trailing 6-month period

29.09%

3.11%

+25.98%

Volatility (1Y)

Calculated over the trailing 1-year period

37.54%

3.88%

+33.66%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

44.20%

7.54%

+36.66%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

45.46%

8.27%

+37.19%

Dividends

LGND vs. HYG - Dividend Comparison

LGND has not paid dividends to shareholders, while HYG's dividend yield for the trailing twelve months is around 5.91%.


PositionTTM20252024202320222021202020192018201720162015
HYG
iShares iBoxx $ High Yield Corporate Bond ETF
5.91%5.71%6.01%5.74%5.30%4.02%4.88%4.99%5.54%5.12%5.27%5.90%
LGND
Ligand Pharmaceuticals Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


LGND and HYG have a correlation of 0.35, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LGND has higher volatility (10.36%) compared to HYG (1.13%). In terms of maximum drawdown, LGND dropped -93.34% vs HYG's -34.25%.

LGND currently has the higher Sharpe Ratio (3.79 vs 1.46), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LGND and HYG

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer